NAD · comparison
NMN vs NAD, and NMN vs NR: a debate run by the people selling both sides
NMN vs NR, with NAD as the destination both reach, is argued over trials that ran 3 to 12 weeks, and almost every page making the case is published by a company selling one of the two compounds. The chemistry is simple; the commercial incentives are not.
Is NMN vs NAD even the right comparison?
Not quite: NMN vs NR is the real choice, two routes to NAD compared in human trials lasting 3 to 12 weeks. Framed as NMN vs NAD vs NR, the question mixes a destination with the routes to it.
NAD, the destination
NAD is a coenzyme required for energy metabolism, DNA repair and sirtuin activity, and its levels decline with age.[1] You cannot usefully swallow it: the intact molecule is broken down during digestion rather than absorbed whole. That single fact is why the supplement category consists of precursors rather than the thing itself.
Nicotinamide riboside and nicotinamide mononucleotide are both vitamin B3 derivatives that the body converts into NAD. Structurally they differ by one phosphate group, with NR the smaller of the two. Niacin and nicotinamide are older, cheaper members of the same family that also raise NAD.
Does NMN get into cells as easily as NR?
Nobody has settled it, and the one clear difference is a single phosphate group.
- NR is small enough to cross using nucleoside transporters.
- NMN carries a phosphate, and the argument runs that it must either be dephosphorylated to NR first or rely on a specific transporter whose importance in humans is contested.
If the mice got antibiotics first, so they don't have a microbiome, then nicotinamide riboside doesn't really work so well.
This is a real biochemical question, and it matters where you meet it. Most pages arguing NMN vs NR are published by NR sellers, NMN sellers, or a company selling a different NAD product entirely.
What do the human trials of NR and NMN show?
Small, mixed signals: the 4 efficacy trials charted below ran 3 to 12 weeks, and none showed a clear functional benefit that a buyer could act on.
The NR record
Early / mixed evidence NR has the longer trial record, beginning with pharmacokinetic work establishing that oral dosing raises blood NAD in humans.[2] Subsequent trials found a blood pressure and aortic stiffness signal in older adults[3] and, less encouragingly, no improvement in insulin sensitivity or metabolic markers in obese men.[4]
The NMN record
NMN's strongest human result is a randomized trial finding improved muscle insulin sensitivity in prediabetic postmenopausal women.[5] Independent evidence summaries for both compounds describe a pattern of small, inconsistent findings across small trials.[6] [7]
Show the numbers as a table
| Measure | Value |
|---|---|
| NR, aged muscle | 21 days |
| NR, older adults | 6 weeks |
| NMN, prediabetic women | 10 weeks |
| NR, obese men | 12 weeks |
Does raising NAD actually improve anything?
Not reliably: in a 21-day trial, NR raised NAD in aged human skeletal muscle and the functional and mitochondrial measures did not improve.[8] That single trial is rarely quoted by either side.
The entire NMN vs NR argument is about which compound raises NAD more efficiently. If raising tissue NAD does not reliably produce a functional change, then winning that argument wins nothing. The debate optimizes a step whose connection to the outcome is unproven.
Show the numbers as a table
| When | Event | Detail |
|---|---|---|
| 2016 | NR pharmacokinetics | Oral NR raises blood NAD |
| 2018 | NR, older adults | Blood pressure signal |
| 2018 | NR, obese men | 12 weeks, no insulin gain |
| 2019 | NR, aged muscle | NAD up, function flat |
| 2021 | NMN, women | Insulin sensitivity up |
Why does NR have more research than NMN?
Commercial history, mostly: NR's cited human record starts in 2016, five years before the first NMN efficacy trial here. A patented NR form reached market earlier and its owner funded trials, a legitimate way for evidence to accumulate and a reason the literature is not a neutral sample. Several NMN trials have similar commercial involvement on the other side.
In the NMN vs NR literature, volume of research is not quality of result. Some of the most deflating findings in the field come from NR trials, precisely because more of them were run.
Why did NMN disappear from store shelves?
Because in 2022 the FDA concluded that NMN was excluded from the dietary supplement definition, having previously been authorized for investigation as a drug, and major retailers delisted it. It is the one practical distinction that has affected buyers. The position later shifted and availability returned.
NR has not faced that problem, which is the clearest practical NMN vs NR difference. If you want the compound with the least regulatory turbulence, that is a real, if unglamorous, reason to prefer it. Our page on the safety picture covers the verification problem that affects both.
Is there a cheaper way to raise NAD?
Yes: niacin and nicotinamide raise NAD at a fraction of the cost of NMN or NR, with decades of use behind them, and exercise supports NAD status with no purchase at all.
Niacin and nicotinamide
Niacin causes flushing at higher doses, which is the main reason it lost the marketing battle to compounds that do not.
Exercise
Exercise also supports NAD status through the body's own salvage pathway, with the largest evidence base of anything discussed here and no purchase required. It appears in none of the comparison pages, for reasons that are not scientific.
Can NMN vs NR be settled on outcomes?
Not yet: across human trials lasting 3 to 12 weeks, neither compound has convincingly moved an outcome. What is left is preference between a compound with more trials and steadier regulatory footing, and one with a phosphate group and an equally uncertain benefit.
Our reviews of the NAD booster category and NMN products specifically apply that standard, and our explainer on NAD itself covers the biology the whole argument depends on.
Frequently asked questions
How long did the longest NR and NMN trials cited here run?
Twelve weeks at most. The NR trial in obese men ran 12 weeks and the NMN trial in prediabetic women ran 10. Nothing in this record tells you what happens after a year of use, let alone the decades an aging claim implies.
Can a blood NAD test show whether a precursor is working?
It can show that NAD went up, and that is all. The 2019 muscle trial raised tissue NAD without improving function, so a higher reading is evidence the capsule was absorbed, not evidence it did anything useful for you.
Can you take NAD directly?
Swallowing NAD itself makes little sense, because the intact molecule is broken down in digestion rather than absorbed whole. That is the entire reason the precursor supplements exist. Intravenous NAD bypasses the problem and is expensive, uncomfortable and no better evidenced.
Is it safe to take NR and NMN together?
No safety signal suggests otherwise, and no study has tested the combination. Since both feed the same pathway to the same endpoint, taking both is mostly a way to spend twice as much on the same uncertain hypothesis.
Did NR face the same regulatory problem as NMN?
No. NR was not caught by the 2022 FDA position that led major retailers to delist NMN. That is a practical difference in availability, not evidence that NR works better or that either product matches its label.
Is there a downside to taking NMN?
Reported side effects are mild. The real downsides are cost, an unproven benefit, an evidence base measured in weeks rather than years, and a category with no pre-market verification of what is actually in the capsule.
What to avoid when taking NMN?
Nothing specific is documented as an interaction. The more useful caution is to avoid assuming the label is accurate, and to mention it to your prescriber if you take medication for diabetes given the insulin sensitivity findings.
Why do I feel weird when I take NMN?
Mild nausea, headache or flushing are the reported effects, and taking it late in the day can disturb sleep for some people. If a product produces marked flushing, check whether it also contains niacin or nicotinamide.
Does NR have more research than NMN?
Yes, by a clear margin, largely because a patented form has been commercialized for longer and funded trials. More research is not the same as better results, and some of the most awkward findings in this field come from NR trials.
What is the CD38 argument?
CD38 is an enzyme that degrades NAD and becomes more active with age. Some evidence suggests NR also inhibits it, which would be a second advantage alongside raising the precursor. This argument appears mainly in material published by NR sellers, which is worth knowing while weighing it.
Is niacin a cheaper alternative?
Yes, and it raises NAD effectively. The trade-off is flushing at higher doses, and nicotinamide, the non-flushing form, has its own considerations. Neither has a longevity result either, which puts all four compounds in the same evidential position at very different prices.
What does David Sinclair take?
Individual researchers' personal regimens are frequently cited in this debate and carry no evidential weight. Several prominent figures also have commercial interests in the compounds discussed, which is worth knowing before treating a personal choice as data.
Does raising NAD help at all?
That is the question underneath the entire comparison and it remains open. NAD declines with age and both compounds raise it. A trial that raised NAD in muscle without improving muscle function is the most important result nobody in the marketing quotes.
So which should someone buy?
If the honest answer is unsatisfying, that is because the evidence is. Either compound is defensible as a low-risk bet on a plausible mechanism. Neither is defensible as a purchase of demonstrated benefit, and the choice between them is currently a choice between marketing departments.
References
8 sources, all link-checked; oldest check
- Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Elhassan YS et al. Cell Reports 2019;28(7):1717–1728.e6.Raised muscle NAD+ metabolites without a matching change in functional performance.Verified Sep 15, 2026
- Nicotinamide riboside is uniquely orally bioavailable in mice and humans. Trammell SAJ et al. Nature Communications 2016;7:12948.Verified Sep 15, 2026
- Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Yoshino M et al. Science 2021;372(6547):1224–1229.Publisher blocks automated checks · last tried Sep 15, 2026
- A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Dollerup OL et al. American Journal of Clinical Nutrition 2018;108(2):343–353.12 weeks, 2 g/day: safe, but no improvement in insulin sensitivity or body composition.Verified Sep 15, 2026
- Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Martens CR et al. Nature Communications 2018;9:1286.Randomized, placebo-controlled; raised NAD+, no clear functional outcome.Verified Sep 15, 2026
- Nicotinamide riboside (NR): evidence summary. Examine.com.Publisher blocks automated checks · last tried Sep 15, 2026
- Nicotinamide mononucleotide (NMN): evidence summary. Examine.com.Publisher blocks automated checks · last tried Sep 15, 2026
- NAD+ supplements: can they really slow down aging?. Cleveland Clinic Health Essentials, 26 February 2026.Mainstream clinical overview; notes NAD+ itself is a large molecule and that most products supply precursors instead.Verified Sep 15, 2026
Every link above is re-requested on a schedule by an automated checker; the date shown is when it last answered. Publishers that block automated requests are marked as such rather than reported broken. Our editorial standards explain how a source gets cited here in the first place.
Filed by the Rapamycin.store evidence desk. Each source is re-checked when the page is reviewed.
Own a longevity or health brand?
Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.